Skip to content

Clinical trial of an oropharyngeal swab robot

Oropharyngeal swab robot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112763
Enrollment
Unknown
Registered
2025-11-19
Start date
2020-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory tract infections

Interventions

Group One:Oropharyngeal swab robot - rigid end effector specimen collection
Group Two:Oropharyngeal swab robot - soft end effector specimen collection
Control Group:Manual specimen collection

Sponsors

Southern University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Subjects who fulfill any of the following criteria are eligible (definitions for these categories should be based on the current editions of documents such as the "Diagnosis and Treatment Protocol for COVID-19" and the "Surveillance Protocol for COVID-19 Cases" issued by the China CDC): 1) Have epidemiological history. 2) Be individuals returning to work or school. 3) Present with fever and/or respiratory symptoms. 4) Be a clinically suspected case.

Exclusion criteria

Exclusion criteria: Subjects shall be excluded from the trial if any of the following conditions apply: 1) Failure to meet any of the above inclusion criteria. 2) Patients with overly sensitive throats who are prone to vomiting reactions. 3) Patients who exhibit rejection or fear towards the oropharyngeal swab robot. 4) Children, pregnant or lactating women, are not considered for trial participation. 5) Individuals who are impaired in consciousness or have a severe cognitive disability that hinders effective communication with healthcare personnel. 6) Individuals with cardiac pacemakers or other implanted electronic devices; 7) History of orthognathic surgery, presence of oral ulcers, or any other condition that restricts normal oral movement. 8) Participation in any other clinical trial within 60 days prior to enrollment. 9) Any other condition deemed by the investigator as unsuitable for trial participation.

Design outcomes

Primary

MeasureTime frame
Cell count;Microbial colony diversity;

Secondary

MeasureTime frame
Cycle Threshold value;DNA concentration;Positive detection rate;

Countries

China

Contacts

Public ContactWang Hongqiang

Southern University of Science and Technology

wanghq6@sustech.edu.cn+86 139 2654 8466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026